<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Sch of Psychology</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7561CBD8-8D97-4798-B555-3F2F4AC52FDC"><gtr:id>7561CBD8-8D97-4798-B555-3F2F4AC52FDC</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Norman</gtr:otherNames><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/36615221-6D4C-4D80-BBEC-B49B39355866"><gtr:id>36615221-6D4C-4D80-BBEC-B49B39355866</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:surname>King</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6547C0B1-68FD-4409-86CB-C572B354DE96"><gtr:id>6547C0B1-68FD-4409-86CB-C572B354DE96</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Lambert</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E4AE7901-605D-408B-93B7-91A4C5F99ED5"><gtr:id>E4AE7901-605D-408B-93B7-91A4C5F99ED5</gtr:id><gtr:firstName>Delia</gtr:firstName><gtr:surname>Belelli</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802715"><gtr:id>664F93DB-1F37-4126-B38C-1AE03AB6C66D</gtr:id><gtr:title>Molecular and physiological mechanism of GABA(A) receptor function in striatal circuits underlying addiction</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802715</gtr:grantReference><gtr:abstractText>Addictive drugs have in common that they influence the function of the brain?s reward pathways. A central structure in these pathways is the nucleus accumbens. We already know that the accumbens receives information about external events that indicate the availability of rewards from other parts of the brain such as the cortex and amygdala, and integrates that information with another important input, from the midbrain, that uses dopamine as its chemical messenger. The role of these systems in signalling reward has been well explored. However, the nucleus accumbens itself consists almost exclusively of nerve cells that use a quite different chemical messenger, GABA. Surprisingly little is known of how these GABAergic cells function to integrate the signals from cortex and amygdala with those from dopamine systems, yet this function lies at the heart of reward signalling. We have recently discovered that GABA signalling in reward depends upon a particular subtype of GABA receptor that is found at high densities in the accumbens. However, we have no real knowledge of how this system functions. In this project we will develop new tools that will allow us to explore the function of this particular subtype of GABA receptor, and how it interacts with other GABA receptors in determining drug-seeking behaviour. A better understanding of this process may allow us to develop new drugs to treat addictions.</gtr:abstractText><gtr:technicalSummary>Understanding the neurobiological mechanisms by which drugs become addictive is essential for formulating new therapeutic approaches to combat addiction. GABAergic medium spiny neurons (MSNs) in the nucleus accumbens are a critical part of the underlying neural circuitry of addiction, integrating dopaminergic inputs from the ventral tegmental area with excitatory glutamatergic inputs from cortex, amygdala and hippocampus. The importance of GABAergic neurotransmission in the processes leading to addiction is further supported by data we have collected across species: A polymorphism in gene expressing the GABA(A) receptor alpha2 subunit in humans associates with an increased vulnerability to addiction; and studies using alpha2 knockout and knockin mice show that these receptors are both necessary and sufficient for cocaine facilitated behavioural sensitisation and conditioned reinforcement. Here we seek to further these studies through four specific aims: 1) Identifying the synaptic and extrasynaptic GABA(A)Rs in specific MSN populations; 2) Establishing by electrophysiology changes GABA(A)R function after repeated cocaine exposure; 3) Establishing the regional localization of alpha2 GABA(A)R mediated actions of cocaine by cFos immunocytochemistry; and 4) developing new tools for localized down-regulation of alpha2 GABA(A)Rs in vivo. The proposed pilot studies will provide proof of principle data for future proposals to determine the mechanisms by which GABA(A)R subtypes are involved in the progression to drug addiction. These results can be directly translated into humans where we can pinpoint ?at risk individuals? and use an informed approach to target and reverse chronic changes in the addiction neurocircuitry with selective GABAergic drugs.</gtr:technicalSummary><gtr:fund><gtr:end>2010-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>246794</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medicine, Dentistry &amp; Nursing</gtr:department><gtr:description>GABA(A) group</gtr:description><gtr:id>FF257D68-E363-40DF-AF00-06E9A0B62939</gtr:id><gtr:impact>PMID: 20133874
Sussex - Behaviour and molecular biology. Dundee - electrophysiology.</gtr:impact><gtr:outcomeId>eZgR3ksoM5Q-1</gtr:outcomeId><gtr:partnerContribution>Collaboration facilitated by this grant</gtr:partnerContribution><gtr:piContribution>Collaborative work on GABA(A) receptor subtyoes incliding Alpha2, Alpha4 and delta containing receptors between the Universities of Sussex and Dundee</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>113800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Industrial CASE studentship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F81A8CEB-6198-41E1-BC12-50B2B94E60D3</gtr:id><gtr:outcomeId>5458b76d13e132.94911935</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>999999</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Addiction Research Strategy</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1000008</gtr:fundingRef><gtr:id>B3F74574-B1BB-4EE9-B970-EB41F5E314BB</gtr:id><gtr:outcomeId>tDtJaKcectZ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Royal College of Psychiatrists</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>909E14BB-1531-4A72-A9B5-0F1A23AD527A</gtr:id><gtr:outcomeId>m8XJxTfjaoS</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>shRNAi construct and viral particle for intracerebral injection and in vivo analysis of gene function</gtr:description><gtr:id>6EB8917E-8E9C-4A35-A6B2-4D0F85E99E62</gtr:id><gtr:impact>Allows regions and temporal specific analysis of gene function not possible with constitutive knockout animals</gtr:impact><gtr:outcomeId>ge3BjQQRawA</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Lentivirus to knockdown Gabra2 expression in mice</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B448084F-20C0-46FA-87D5-9B89900B9EEC</gtr:id><gtr:title>GABAreceptor subtype involvement in addictive behaviour.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9648c427cf7e119d5c5bc458f6e0ef"><gtr:id>cf9648c427cf7e119d5c5bc458f6e0ef</gtr:id><gtr:otherNames>Stephens DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>58b5561939d094.08424540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E22089EA-DDA0-4F1D-98A8-1309C769B6DA</gtr:id><gtr:title>Rodent models of treatment-resistant depression.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/355806f74d831ab52abec23cc4160185"><gtr:id>355806f74d831ab52abec23cc4160185</gtr:id><gtr:otherNames>Caldarone BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>585d59376db493.60392096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>246A699A-612D-4A92-9070-2BAFC2A3A6ED</gtr:id><gtr:title>Tonic inhibition of accumbal spiny neurons by extrasynaptic a4?d GABAA receptors modulates the actions of psychostimulants.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f1090fb8dc6db808afca861cb7bace0"><gtr:id>0f1090fb8dc6db808afca861cb7bace0</gtr:id><gtr:otherNames>Maguire EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_540e167e167675d13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A8BDF8E-D83D-41AB-A2BC-A045CD534A74</gtr:id><gtr:title>Deletion of the gabra2 gene results in hypersensitivity to the acute effects of ethanol but does not alter ethanol self administration.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d86a37a8e51f63a523c035fb39e6196"><gtr:id>0d86a37a8e51f63a523c035fb39e6196</gtr:id><gtr:otherNames>Dixon CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15778_28_23115637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81AA5561-C74D-43C0-8934-B702CC8F1F77</gtr:id><gtr:title>Deletion of the GABAA a2-subunit does not alter self administration of cocaine or reinstatement of cocaine seeking.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d86a37a8e51f63a523c035fb39e6196"><gtr:id>0d86a37a8e51f63a523c035fb39e6196</gtr:id><gtr:otherNames>Dixon CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>pm_540e167e1677384b1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB144E9C-AEBC-4278-AC2D-D796393A8F7D</gtr:id><gtr:title>Motivational Effects of Methylphenidate are Associated with GABRA2 Variants Conferring Addiction Risk.</gtr:title><gtr:parentPublicationTitle>Frontiers in behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb946697bc0f9579fb05719e815034d2"><gtr:id>bb946697bc0f9579fb05719e815034d2</gtr:id><gtr:otherNames>Duka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-5153</gtr:issn><gtr:outcomeId>56d42c6f351231.53533307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D16899E1-1D07-42D1-86E7-BA644116430D</gtr:id><gtr:title>Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18bfc7707aff90dd40d5eab68c9e6c0"><gtr:id>a18bfc7707aff90dd40d5eab68c9e6c0</gtr:id><gtr:otherNames>Leeman RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>doi_13472_9_00192_x_</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E0F4AE-F882-4A2F-BC7A-AAC6903259F5</gtr:id><gtr:title>Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_540e167e1675c8097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81BB456A-DD34-498C-89A9-FD3D068F90DE</gtr:id><gtr:title>Cocaine effects on mouse incentive-learning and human addiction are linked to alpha2 subunit-containing GABAA receptors.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d86a37a8e51f63a523c035fb39e6196"><gtr:id>0d86a37a8e51f63a523c035fb39e6196</gtr:id><gtr:otherNames>Dixon CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>oUvuKKGzTxD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79C2C061-004C-465C-A191-CE68DE66097D</gtr:id><gtr:title>Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed509ddca3263f1e05b2db1df46f080d"><gtr:id>ed509ddca3263f1e05b2db1df46f080d</gtr:id><gtr:otherNames>Panzanelli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>ebkn655t3KY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49C7AAD1-4A0F-4D50-A866-E9D1CCE9D515</gtr:id><gtr:title>Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through a4/?2/a5 nicotinic acetylcholine receptors.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b494e448cd5d7f32100d2407700faa1"><gtr:id>6b494e448cd5d7f32100d2407700faa1</gtr:id><gtr:otherNames>Heath CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>2A2E838F_A2A2E838F_A</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802715</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>